Latest Market Expansion News

Cann Group Limited has successfully completed a significant debt restructure and equity raising, improving its financial footing and liquidity to support future growth.

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.

Biome Australia has initiated its first human clinical trial for the proprietary probiotic strain Lactobacillus plantarum BMB18, aiming to validate its benefits for digestive and mood-related symptoms.

Vection Technologies reports a record quarter-to-date cash intake of approximately $14 million and a robust $50 million forward pipeline, underscoring strong momentum across defence, AI, healthcare, and retail sectors.

Janus Electric reports strong progress in truck conversions and US export orders while navigating a delay in expected EVUNI investment funding, secured by interim asset-backed financing.

Vita Life Sciences forecasts solid sales and profit growth for FY2025, driven by strong performances in Malaysia and Singapore, while cautiously managing challenges in China exports.

Swift TV Ltd has locked in pre-sales with five aged care providers, activating 1,246 screens ahead of its official launch and setting the stage for subscription revenue by March 2026.

Metal Powder Works Limited has achieved a major production milestone by successfully manufacturing high-purity silver powder using its patented DirectPowder™ process, positioning itself to serve the booming electric vehicle and electronics sectors.

Flight Centre Travel Group has agreed to acquire UK online cruise leader Iglu for £122 million, boosting its cruise sector footprint and upgrading FY26 profit guidance. The deal promises immediate earnings accretion and strategic expansion into key global markets.

Stakk Limited reveals a striking 566% year-to-date growth in annual recurring revenue, driven by its pivot to a B2B embedded finance platform and strategic US market expansion. The company also secured a $15 million institutional placement, underpinning its ambitious growth plans.

Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.

Jatcorp Limited has announced a fully underwritten pro-rata rights issue to raise approximately $4.2 million, aiming to strengthen working capital and accelerate growth in China and Southeast Asia. Eligible shareholders can subscribe at $0.15 per share with an option for additional shares under a Top-Up Facility.